2021 EAEU regulatory changesJanuary 15, 2021
Readability user testing is requested in EAEU
Does your company know that User Testing of Patient Information Leaflet (PIL testing/ Readability user testing (RUT)) of medicines is requested in EAEU region according to decision of the Eurasian Economic Commission (EEC) No. 88.?
To conduct PIL testing, you should:
Inpharmatis is an international consulting company with more than 15 years’ experience in EAEU, CIS and EU markets in the field of regulatory services for pharmaceutical companies.
We are delighted to propose PIL testing in EAEU performed by Inpharmatis - leading provider with great practical experience and expertise of PIL testing in EAEU region.
Inpharmatis has been involved with readability testing since the beginning of the EU requirement in 2005.
Our approval rates are 100% - leaving aside projects where clients have ignored our initial advice regarding leaflet changes.
If you want to conduct PIL testing and find out further information, please contact us email@example.com.
Webinar: EAEU Regulatory Challenges and OpportunitiesNovember 09, 2020
Readability user testing is requested in EAEUOctober 15, 2020
Inpharmatis & Epista Partnership AnnouncementSeptember 03, 2020
User Testing Instructions Webinar on 30 April in RussianApril 27, 2020
Inpharmatis Team COVID-19 UpdateMarch 30, 2020
Inpharmatis - Winner in EU GMP Inspection TenderMarch 19, 2020
Bебинар: Регистрация и создание досье в электронном формате по новым стандартам ЕАЭСDecember 09, 2019
The EAEU Electronic Submission FormatNovember 20, 2019
Meet us at IV All-Russia GMP Conference 2019September 23, 2019